Search details
1.
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).
Cytotherapy
; 26(1): 25-35, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37897472
2.
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial.
Clin Infect Dis
; 76(3): e116-e125, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-35906838
3.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet
; 398(10295): 121-130, 2021 07 10.
Article
in English
| MEDLINE | ID: mdl-34181880
4.
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score.
Thorax
; 76(9): 920-929, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33632764
5.
Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.
Pharmacol Res
; 115: 168-178, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27888155
6.
Public preferences on written informed consent for low-risk pragmatic clinical trials in Spain.
Br J Clin Pharmacol
; 83(9): 1921-1931, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28419518
7.
Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital.
Br J Clin Pharmacol
; 83(2): 400-415, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27543764
8.
Patients' beliefs regarding informed consent for low-risk pragmatic trials.
BMC Med Res Methodol
; 17(1): 145, 2017 Sep 18.
Article
in English
| MEDLINE | ID: mdl-28923007
9.
Who is willing to participate in low-risk pragmatic clinical trials without consent?
Eur J Clin Pharmacol
; 73(12): 1557-1563, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-28900674
10.
Nonchemotherapy drug-induced agranulocytosis in children detected by a prospective pharmacovigilance program.
Pediatr Hematol Oncol
; 33(7-8): 441-456, 2016.
Article
in English
| MEDLINE | ID: mdl-27922762
11.
Hepatotoxicity induced by acute and chronic paracetamol overdose in adults. Where do we stand?
Regul Toxicol Pharmacol
; 72(2): 370-8, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25985715
12.
ALDRESS: A Retrospective Pilot Study to Develop a Pharmacological Causality Algorithm for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
J Clin Med
; 13(9)2024 Apr 29.
Article
in English
| MEDLINE | ID: mdl-38731156
13.
Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
Ther Drug Monit
; 35(3): 360-6, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23666575
14.
Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals.
Eur J Clin Pharmacol
; 69(1): 97-110, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-22648277
15.
Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register data.
Clin Transl Sci
; 16(12): 2654-2664, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37890866
16.
Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units.
Clin Transl Sci
; 16(12): 2421-2428, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37818923
17.
Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol.
BMJ Open
; 13(7): e072350, 2023 07 10.
Article
in English
| MEDLINE | ID: mdl-37429687
18.
Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity.
Front Pharmacol
; 14: 1292416, 2023.
Article
in English
| MEDLINE | ID: mdl-37927587
19.
No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study.
Res Pract Thromb Haemost
; 7(1): 100049, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36685004
20.
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).
Vaccine
; 41(48): 7166-7175, 2023 11 22.
Article
in English
| MEDLINE | ID: mdl-37919141